|| | | | | |

Association of mutation to drug resistance

Mutation Gene Species Validation status Validation technique(s) Validation reference(s) Resistance mechanism(s) Validation score
T225A TAC1 C. albicans Validated Site-Directed Mutagenesis; Murine model 17693596
24051054
The T225A mutation in TAC1 disrupts the transcriptional inhibitory domain, leading to hyperactivity of the TAC1 allele and increased expression of drug resistance genes, thereby contributing to azole resistance (PMID: 17693596) 2